Cargando…
Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
Autores principales: | Anasiewicz, Natalie, Seeli, Corsin, Brüggen, Marie-Charlotte, Möhrenschlager, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891745/ https://www.ncbi.nlm.nih.gov/pubmed/36748045 http://dx.doi.org/10.1007/s40629-023-00245-w |
Ejemplares similares
-
Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbidities
por: Anasiewicz, Natalie, et al.
Publicado: (2022) -
Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
por: Oosterhaven, Jart A.F., et al.
Publicado: (2019) -
Dupilumab for atopic dermatitis
Publicado: (2019) -
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)